Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 7, 2015, Pages 3966-3972

  Wand, Matthew E ^a   Baker, Kate S ^b   Benthall, Gabriel ^a   McGregor, Hannah ^a   McCowen, James W I ^a   Deheer Graham, Ana ^a   Sutton, J Mark ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CATION; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; DISINFECTANT AGENT; HYDROGEN PEROXIDE; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TRICLOSAN; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BIOFILM; CONTROLLED STUDY; GALLERIA MELLONELLA; GENE INSERTION; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SKIN; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOTH; PATHOGENICITY; PENICILLIN RESISTANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOFILMS; CHLORHEXIDINE; DISINFECTANTS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOTHS; MUTAGENESIS, INSERTIONAL; PENICILLIN RESISTANCE; TRICLOSAN; VIRULENCE FACTORS;

EID: 84931275547     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05009-14     Document Type: Article

References (43)

1. Lübbert C, Lippmann N, Busch T, Kaisers UX, Ducomble T, Eckmanns T, Rodloff AC. 2014. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae after a large single center outbreak in Germany. Am J Infect Control 42:376-380. http://dx.doi.org/10.1016/j.ajic.2013.12.001.
2. Giuffrè M, Bonura C, Geraci DM, Saporito L, Catalano R, Di Noto S, Nociforo F, Corsello G, Mammina C. 2013. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect 85:233-236. http://dx.doi.org/10.1016/j.jhin.2013.08.004.
3. Hong SK, Yong D, Kim K, Hong SS, Khosnayar T, Song W, Roh KH, Jeong SH, Lee K, Chong Y. 2013. First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea. J Clin Microbiol 51:3877-3879. http://dx.doi.org/10.1128/JCM.01730-13.
4. Jacoby GA, Sutton L. 1991. Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicob Agents Chemother 35:164-169. http://dx.doi.org/10.1128/AAC.35.1.164.
5. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicob Agents Chemother 45:1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161.2001.
6. Centers for Disease Control and Prevention. 2013. Antibiotic resistant threats in the United States. http://www.cdc.gov/drugresistance/threat-report-2013/pdf.
7. Hughes VM, Datta N. 1983. Conjugative plasmids in bacteria of the pre-antibiotic era. Nature 302:725-726. http://dx.doi.org/10.1038/302725a0.
8. Fleming A. 1929. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenza.Br J Exp Pathol 10:226-236.
9. Abraham EP, Chain E. 1940. An enzyme from bacteria able to destroy penicillin. Nature 146:837. http://dx.doi.org/10.1038/146837a0.
10. Wand ME, McCowen JWI, Nugent PG, Sutton JM. 2013. Complex interactions of Klebsiella pneumoniae with the host immune system in a Galleria mellonella infection model. J Med Microbiol 62:1790-1798. http://dx.doi.org/10.1099/jmm.0.063032-0.
11. Keys CJ, Dare DJ, Sutton H, Wells G, Lunt M, McKenna T, McDowall M, Shah HN. 2004. Compilation of a MALDI-TOF mass spectral database for the rapid screening and characterisation of bacteria implicated in human infectious diseases. Infect Genet Evol 4:221-242. http://dx.doi.org/10.1016/j.meegid.2004.02.004.
12. Ceri H, Olsen ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37:1771-1776.
13. Wand ME, Bock LJ, Turton JF, Nugent PG, Sutton JM. 2012. Acineto-bacter baumannii virulence is enhanced in Galleria mellonella following biofilm adaptation. J Med Microbiol 61:470-477. http://dx.doi.org/10.1099/jmm.0.037523-0.
14. Wand ME, Müller CM, Titball RW, Michell SL. 2011. Macrophage and Galleria mellonella infection models reflect the virulence of naturally occurring isolates of B. pseudomallei, B. thailandensis and B. oklahomensis. BMC Microbiol. 11:11. http://dx.doi.org/10.1186/1471-2180-11-11.
15. Turton JF, Perry C, Elogohari S, Hampton CV. 2010. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol 59:541-547. http://dx.doi.org/10.1099/jmm.0.015198-0.
16. Fevre C, Passet V, Deletoile A, Barbe V, Frangeul L, Almeida A, Sansonetti P, Tournebize R, Brisse S. 2011. PCR-based identification of Klebsiella pneumoniae subsp. Rhinoscleromatis, the agent of Rhinoscleroma. PLoS Negl Trop Dis 5:e1052. http://dx.doi.org/10.1371/journal.pntd.0001052.
17. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P. 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. http://dx.doi.org/10.1371/journal.pone.0004982.
18. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821-829. http://dx.doi.org/10.1101/gr.074492.107.
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410. http://dx.doi.org/10.1016/S0022-2836(05)80360-2.
20. Stamatakis A. 2006. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics 22:2688-2690. http://dx.doi.org/10.1093/bioinformatics/btl446.
21. Edgar RC. 2004. MUSCLE: multiple sequence alignment method with reduced time and space complexity. Nucleic Acids Res 32:1792-1797. http://dx.doi.org/10.1093/nar/gkh340.
22. Rammelkamp CH, Maxon T. 1942. Resistance of Staphylococcus aureus to the action of penicillin. Proc Soc Exp Biol Med 51:386-389. http://dx.doi.org/10.3181/00379727-51-13986.
23. Matthew M, Hedges RW, Smith JT. 1979. Types of β-lactamase determined by plasmids in Gram-negative bacteria. J Bacteriol 138:657-662.
24. Nugent ME, Hedges RW. 1979. The nature of the genetic determinant for the SHV-1 β-lactamase. Mol Gen Genetic 175:239-243. http://dx.doi.org/10.1007/BF00397222.
25. Livermore DM. 2000. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 16:S3-S10. http://dx.doi.org/10.1016/S0924-8579(00)00299-5.
26. Thomson CJ, Amyes SGB. 1993. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland. Epidemiol Infect 110:117-125. http://dx.doi.org/10.1017/S0950268800050743.
27. Wu PJ, Shannon K, Philips I. 1994. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob Agents Chemother 38:494-498. http://dx.doi.org/10.1128/AAC.38.3.494.
28. Nüesch-Inderbinen MT, Hächler H, Kayser FH. 1995. New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV β-lactamases. Antimicrob Agents Chemother 39:1726-1730. http://dx.doi.org/10.1128/AAC.39.8.1726.
29. Turner MS, Andersson P, Bell JM, Turnidge JD, Harris T, Giffard PM. 2009. Plasmid-borne blaSHV genes in Klebsiella pneumoniae are associated with strong promoters. J Antimicrob Chemother 64:960-964. http://dx.doi.org/10.1093/jac/dkp338.
30. Fan F, Yan K, Wallis NG, Reed S, Moore TD, Rittenhouse SF, DeWolf WE, Jr, Huang J, McDevitt D, Miller WH, Seefeld MA, Newlander KA, Jakas DR, Head MS, Payne DJ. 2002. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 46:3343-3347. http://dx.doi.org/10.1128/AAC.46.11.3343-3347.2002.
31. Chuanchuen R, Beinlich K, Hoang TT, Becher A, Karhoff-Schweizer RR, Schweizer HP. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing mexCD-OprJ. Antimicrob Agents Chemother 45:428-432. http://dx.doi.org/10.1128/AAC.45.2.428-432.2001.
32. Skovgaard S, Nielsen LN, Larsen MH, Skov RL, Ingmer H, Westh H. 2013. Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. PLoS One 8:e62197. http://dx.doi.org/10.1371/journal.pone.0062197.
33. Kazama H, Hamashima H, Sasatsu M, Arai T. 1998. Distribution of the antiseptic-resistance genes qacE and qacE delta 1 in Gram-negative bacteria. FEMS Microbiol Lett 159:173-178.
34. Kücken D, Feucht H, Kaulfers P. 2000. Association of qacE and qacE delta 1with multiple resistance to antibiotics and antiseptics in clinical isolates of Gram-negative bacteria. FEMS Microbiol Lett 183:95-98. http: //dx.doi.org/10.1016/S0378-1097(99)00636-9.
35. Abuzaid A, Hamouda A, Amyes SG. 2012. Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacΔE and qacE efflux pump genes and antibiotic resistance. J Hosp Infect 81:87-91. http://dx.doi.org/10.1016/j.jhin.2012.03.003.
36. Skovgaard S, Larsen MH, Nielsen LN, Skov RL, Wong C, Westh H, Ingmer H. 2013. Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC. J Antimicrob Chemother 68:2226-2233. http://dx.doi.org/10.1093/jac/dkt182.
37. Siu LK, Fung CP, Chang FY, Lee N, Yeh KM, Koh TH, Ip M. 2011. Molecular typing and virulence analysis of serotype K1 Klebsiella pneumoniae strains isolated from liver abscess patients and stool samples from non-infectious subjects in Hong Kong, Singapore and Taiwan. J Clin Micobiol 49:3761-3765. http://dx.doi.org/10.1128/JCM.00977-11.
38. Insua JL, Llobet E, Moranta D, Pérez-Gutiérrez C, Tomás A, Garmendia J, Bengoechea JA. 2013. Modelling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect Immun 81: 3552-3565. http://dx.doi.org/10.1128/IAI.00391-13.
39. Murphy CN, Clegg S. 2012. Klebsiella pneumoniae and type 3 fimbriae: nosocomial infection, regulation and biofilm formation. Future Microbiol 7:991-1002. http://dx.doi.org/10.2217/fmb.12.74.
40. Stahlhut SG, Chattopadhyay S, Kisiela DI, Hvidtfeldt K, Clegg S, Struve C, Sokurenko EV, Krogfelt KA. 2013. Structural and population characterization of MrkD, the adhesive subunit of type 3 fimbriae. J Bacteriol 195:5602-5613. http://dx.doi.org/10.1128/JB.00753-13.
41. Murray GRE. 1985. More on bacterial longevity: the Murray collection. ASM News 51:261-262.
42. Sutton A, Buencamino R, Eisenstark A. 2000. rpoS mutants in archival cultures of Salmonella enterica serovar typhimurium. J Bacteriol 182: 4375-4379. http://dx.doi.org/10.1128/JB.182.16.4375-4379.2000.
43. Spira B, de Almeida Toledo R, Maharian RP, Ferenci T. 2011. The uncertain consequences of transferring bacterial strains between laboratories-rpoS instability as an example. BMC Microbiol 11:248. http://dx.doi.org/10.1186/1471-2180-11-248.